LuSys 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Saliva Test)

FDA Device Recall #Z-0716-2022 — Class I — January 13, 2022

Recall Summary

Recall Number Z-0716-2022
Classification Class I — Serious risk
Date Initiated January 13, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Lusys Laboratories, Inc.
Location San Diego, CA
Product Type Devices
Quantity 14,745 kits

Product Description

LuSys 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Saliva Test)

Reason for Recall

COVID-19 test kits (Antibody Rapid Test kit and Antigen Rapid Test Kit) are not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of CA, NC, NV, OH, TN and TX. The countries of Canada, China, and Mexico. Pending additional information for a complete Consignee Listing

Lot / Code Information

Part Number: I-114(S) Lot Numbers: All Lots due to not having an authorized Emergency Use Authorization (EUA)

Other Recalls from Lusys Laboratories, Inc.

Recall # Classification Product Date
Z-0717-2022 Class I Luscient Diagnostics 2nd Generation of COVID-19... Jan 13, 2022
Z-0718-2022 Class I COVID-19 IgG/IGM Antibody Test For Detection of... Jan 13, 2022
Z-1329-2015 Class I Ebola GP IgX Blood, Serum, Plasma, Cassette, Ca... Mar 13, 2015
Z-1334-2015 Class I Ebola Virus Antigen Blood, Catalog No. I-123 (A... Mar 13, 2015
Z-1335-2015 Class I Ebola Virus GP-VP IgS, Catalog No. I-124 vir... Mar 13, 2015

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.